From policy to practice: Experiences from the ECHO trial following revisions of the WHO medical eligibility criteria for contraceptive use (MEC) guidance on DMPA-IM

• Asıl Yazarlar: Petrus Steyn (Yazar), Mags Beksinska (Yazar), Melanie Pleaner (Yazar), Hui-Zhen Tam (Yazar), Jenni Smit (Yazar), Kathy Baisley (Yazar), Douglas Taylor (Yazar), Mandisa Singata-Madliki (Yazar), G. Justus Hofmeyr (Yazar), Thesla Palanee-Phillips (Yazar), James N. Kiarie (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Elsevier, 2024-01-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Objectives: In 2017, the World Health Organization (WHO) medical eligibility criteria (MEC) for contraception category for intramuscular depot medroxyprogesterone acetate (DMPA-IM) was changed from MEC category 1 to 2 for women at high risk of HIV acquisition. We assessed the impact of communicating...